New Medical Technologies in rehabilitations robotics: Experience from Slovenia Zlatko Matjačić University rehabilitation institute Ljubljana, SLOVENIA.

Slides:



Advertisements
Similar presentations
How to Explain Device Reimbursement to your CEO The Medical Device Regulatory and Compliance Congress Barbara J. Calvert March 29, 2006.
Advertisements

Drug Situation in East and Southeast Asia ARF Seminar on Narcotics Control Xi'an, China September 2007.
Technology Appraisal of Medical Devices at NICE – Methods and Practice Mark Sculpher Professor of Health Economics Centre for Health Economics University.
OECD Water Programme Sustainable Financing to Ensure Affordable Access to Water and Sanitation EUWI Finance Working Group World Water Week Stockholm, Aug.20.
Importance of community-based services for persons with disabilities: Availability and quality International frame June 2012,Belgrade Dr.Vasilka.
© Fraunhofer ISI Seite 1 Smoke screens and sacred fires: Translational research and grand challenges in European biomedicine. Etienne Vignola-Gagné Fraunhofer.
External Validity of Trials. Background External or ecological validity refers to whether the results of the trial can be generalised to the general clinical.
The ESFRI context. Clinical Trials as Instruments supporting Evidence-based Medical Practice. Dr Rafael de Andres Medina, Instituto de Salud Carlos III.
Single Subject Methods Application of experimental methods to the study of an “n of 1” to arrive at a clinically relevant answer for an individual patient.
Medical tools for the future: Cost-effective solutions based on advanced technologies L. Enrique SucarINAOE M é xico Panel on Health Informatics Los Retos.
Group of Robotics and Articular Biomechanics
Agricultural Policy Analysis Prof. Samuel Wangwe Executive Director REPOA 28 th July 2012.
David Holmes EMEA Business director. A simplified version of a complex system.
Current Approaches in European Health Care Policy What models can balance the needs of payors and industry?
A stroke is the leading cause of permanent impairment and disability. Pending a radical cure, patients recovering from a stroke will continue to require.
Evidence based implementation for quality and health promotion in hospitals Professor Jos Kleijnen Director Centre for Reviews and Dissemination University.
Bernard A Fox, PhD Immediate Past President and Chair, Executive Council Society for Immunotherapy of Cancer (SITC) Defining the Critical Hurdles in Cancer.
Affordable, sustainable water and sanitation services: An OECD perspective on pricing 5 th World Water Forum, 18 March 2009 – Istanbul, Turkey Monica Scatasta.
HTA cooperation in the EU EPF workshop Jérôme Boehm 18 May 2010.
AIFA European Conference on Clinical Research for Decision Making Sergio Dompé - Farmindustria Rome, March 30th, 2007 Access to market by new medicines.
Is there a future for the NHS and how does Surgery fit in it? Mahiben Maruthappu University of Oxford.
Secondary Translation: Completing the process to Improving Health Daniel E. Ford, MD, MPH Vice Dean Johns Hopkins School of Medicine Introduction to Clinical.
An introduction to Roessingh Research and Development Prof. dr. ir. Hermie J. Hermens.
Jeroen de Joode (ECN/Delft University of Technology) Michiel van Werven (ECN) An analysis of potential bottlenecks Optimal Design of Future Electricity.
The development and evaluation of an electric scooter simulation program Michiel JA Jannink (PhD)*, V. Erren (PT), A.C. de Kort (MD), Ir. H. vd Kooij (Phd),
ACTUATING SOFT ROBOTIC EXOSKELETONS: THE POTENTIAL AND PRACTICALITY Thomas Hinds and Rachel Round What is Soft Robotics? Therapy and Rehabilitation Applications.
University Medical City Re-designing the Health Care Environment Abdulrahman Al-Muammar, MD CEO, King Saud University Medical City International Patient.
Biotechnology Industry Organization (BIO) Risk Management Public Workshop Day 1 - April 9, 2003 Risk Assessment in Drug and Biological Development Joanna.
European Patients’ Academy on Therapeutic Innovation Ethical and practical challenges of organising clinical trials in small populations.
ENGINEERING DESIGN PROCESS. OBJECTIVES IDENTIFY THE STEPS OF THE ENGINEERING DESIGN PROCESS. DETERMINE CRITERIA FOR THE DEVELOPMENT OF A NEW TECHNOLOGY.
RECENT ADVANCES IN PROVISION OF PRIMARY HEALTH CARE BY MISSION ORGANIZATIONS THE EFFECT OF AN EDUCATIONAL INTERVENTION ON USE OF ANTIBIOTICS IN THE TREATMENT.
European Innovation Partnership (EIP) on Active and Healthy Ageing Karolina Lagiewka DG SANCO, 02 Strategy and Analysis.
The role of the insurance physician in return to work. An international survey Corina Oancea, Soren Brage, Freddy Falez, Wout de Boer 21 st EUMASS Congress.
PRAGMATIC Study Designs: Elderly Cancer Trials
Serving society Stimulating innovation Supporting legislation Overview of Benchmarking Exercises 1 and 2 Zsuzsanna Gyenes, PhD European.
GAP BETWEEN DECREASE OF WORK ABILITY AND INCREASE OF WORK PLACE DEMANDS dr. Marija Molan, higher health councillor University Clinical Centre Ljubljana,
EXTENDED OCCUPATIONAL REHABILITATION Ksenija Šterman, MD, Specialist for Occupational, Traffic and Sports Medicine Ljubljana,
Integrative or Disintegrating Society?
Device to Augment Movements in Stroke Patients
Session 3 General RIA Training 6–8 July 2009 EuropeAid/125317/D/SER/TR
How To Design a Clinical Trial
Clinical Trial Design for Second Generation TAVI - Academic View
Health Technology Assessment
Us Healthcare System.
A stroke is the leading cause of permanent impairment and disability
Clinical Research Contribution towards improving Clinical Care
Craig Earle, MD MSc FRCPC
Case Studies in Big Data and Analysis
Expedited Drug Approval Programs
Placebo and Outcome Measurement
“New Gene Therapy Treatments Will Carry Whopping Price Tags”
Strategies to incorporate pharmacoeconomics into pharmacotherapy
Eric Heiden MSc. Avi Nativ PT PhD. NeuroGym FIT NeuroGym Technologies
Črtomir Bitenc and Aleksandra Tabaj, PhD.
Critical Reading of Clinical Study Results
Why it Makes Sense to Travel Overseas for Stem Cell Therapy Treatment.
Strength of Evidence; Empirically Supported Treatments
Modernising Europe's universities –
Electrical & Electronics Engineering Department
Challenges and Solutions for the Private Healthcare Industry
Neurostimulation for the Management of Medication-Resistant Epilepsy
Implantable Medical Devices: Accelerating Standards Development to Streamline Regulation Joshua Price | August 2,
Availability and Prices of Generic Medicines in the Private Sector.
Treatment-Resistant Schizophrenia
An Introduction to the NIHR programmes
Alternating attention
Careers in Exercise and Fitness
Mechanisms Vocabulary
Sabaydee.
Presentation transcript:

New Medical Technologies in rehabilitations robotics: Experience from Slovenia Zlatko Matjačić University rehabilitation institute Ljubljana, SLOVENIA

Prof. Zlatko Matjačić

Background Ageing society – increased need for efficient rehabilitation Budgetary constraints – limited institutional rehabilitation facilities Rehabilitation robotics may increase productivity of rehabilitation treatment

Rehabilitation robotics – current situation Complex systems with many DOFs – large investment costs Require substantial donning/doffing time/procedures Application limited to larger rehabilitation centres

Efficacy of rehabilitation robotics Large-scale clinical trials are only few, rather expensive and lack conclusive evidence (due to heterogenity of patients large experimental and control groups are needed) This significantly impedes wide-spreading of rehabilitation robotics to the markets and consequently to clinical environment

An alternative approach Most of current rehabilitation robots originated from research done at universities – over-engineered devices Relevant clinical needs may be adequately addressed with one or at most two DOFs devices – simple rehabilitation robots

Simple rehabilitation robots Advantages: Smaller development costs Shorter time-to-reach market Affordable end price sustainable also for smaller private therapy practices This may result in increased numbers of such devices in clinical practice -> may facilitate in increase of a number of clinical trials -> larger clinical experience & more conclusive evidence

Simple rehabilitation robots – examples from Slovenia Device for training balance during standing - Balance trainer Device for training balance during walking – e-Go Device for training standing-up – Sit-to-stand trainer Device for arm reaching and wrist movement training – Universal haptic drive Device for bilateral arm training – Linear Elliptical Circular Trainer

Balance Trainer Zlatko Matjačić, Thomas Sinkjær, Balance Re-trainer, United States Patent, US 7,086,996, 2006; European Patent, EP , 2008.

E-Go Zlatko Matjačić, Thomas Sinkjær, Balance Re-trainer, United States Patent, US 7,086,996, 2006; European Patent, EP , 2008.

Sit-to-stand trainer J. Oblak, Z. Matjačić, Aufstehtrainer, Deutsche Patent, DE B4, 2013.

MATJAČIĆ, Zlatko, CIKAJLO, Imre, OBLAK, Jakob. Universal haptic drive system : European patent EP B1, 2015; United States patent US 9,233,046 B2, Universal haptic drive

Linear-elliptical-circular trainer Jakob Oblak, Zlatko Matjačić, Treningsgerat, Deutsche Patent DE B3, 2013.

Instead of conclusion Simple rehabilitation robots: Control (should be biologically inspired) Mechanism design (with only few DOFs it is possible to cover a large portion of patients needs) Assessment (RCTs are not very well suited for rehabilitation but there are no better instruments) Reversed order of steps (prototype & limited testings -> product -> market -> clinical practice -> RCTs)

Thank you for your attention